UNIQUE EXPERTISE
Headquartered in Reykjavik, Iceland, deCODE is a global leader in analyzing and understanding the human genome. Using our unique expertise and population resources, deCODE has discovered key genetic risk factors for dozens of common diseases ranging from cardiovascular disease to cancer.
UNIQUE CAPABILITIES
We operate the most productive human gene discovery engine in the world, employing our discoveries to identify genetic variations associated with human disease.
OUR PUBLICATIONS
We regularly publish our discoveries in major, peer-reviewed journals, enabling others to further validate and expand upon our findings.
NEWS
ARUP Laboratories Ink Partnership To Offer deCODE ProstateCancer™ Test
U.S. laboratories and physicians will be able to use their ARUP accounts to order deCODE’s test for assessing risk of prostate cancer Reykjavik, ICELAND, and Salt Lake City, UTAH,– July 20, 2010 – deCODE genetics and ARUP Laboratories today announced a partnership...
deCODE Discovers Genetic Risk Factor Linking Susceptibility to Four Major Vascular Diseases
Points to novel pathway for drug discovery, will be incorporated into tests to improve screening and early detection of abdominal aortic aneurysm, heart attack and PAD Reykjavik, ICELAND, 11 July 2010 – Scientists at deCODE genetics and academic colleagues from the...
Award by the American Society of Human Genetics
At its Annual meeting in October 2017 in Orlando, the American Society of Human Genetics (ASHG), presented Dr. Kári Stefánsson, founder and CEO of deCODE genetics, with the William Allan Award. The award, the top prize given by the society, recognizes a scientist for substantial and far-reaching scientific contributions to human genetics. The ASHG has distributed video footage from the award ceremony. The introduction is given by Professor Mark Daly of Harvard University.